CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Al Mansour Pharmaceuticals Industries Co is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Al Mansour Pharmaceuticals Industries Co
Abo Ghareib, Highway Road
Phone: +964 17823338806p:+964 17823338806 BAGHDAD, Iraq Ticker: IMAPIMAP
Business Summary
Al Mansour Pharmaceuticals Industries Co is an Iraq-based company engaged in the pharmaceutical industry sector. The Company’s products include Ventomaxin, Sulfomaxin and Hustamaxin, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Abdul Rasoul M.Wais
Vice Chairman of the Board, representing Baghdad College of Pharmacy Abdel Moutalib A.Naser
Managing Director, Member of the Board Ishraq A.Al Dahhan
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 16,000,000,000 (As of 12/31/2023)
Stock Exchange: ISX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 17, 2024